Novel non-immunogenic trained immunity inducing small molecule with improved anti-tumor properties

Abstract Trained immunity refers to the non-specific innate immune memory response triggered by the epigenetic and metabolic rewiring of innate immune cells. A strengthened innate immune system significantly improves disease resistance. However, very few trained immunity-inducing molecules have been identified. Almost all molecules for training are primarily immunogenic and then subsequently induce training. Non-immunogenic molecules that induce training could be employed in therapies without the concern of adverse inflammatory reactions. We identified a small molecule, A1155463, that modulates cellular metabolism to induce trained immunity in macrophagesin-vitro. We show that nanomolar concentrations of these compounds uniquely alter only cellular metabolism without leading to apoptosis. We further observed that these compounds could induce training in anin-vivomodel in mice. A1155463 training improved anti-tumor resistance to B16.F10 melanoma cells. The effect was enhanced upon combination with checkpoint therapy. In summary, we report the discovery of a novel trained immunity-inducing small molecule with enhanced anti-tumor properties..

Medienart:

Preprint

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

bioRxiv.org - (2024) vom: 29. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

Ajit, Jainu [VerfasserIn]
Knight, Hannah Riley [VerfasserIn]
Chen, Qing [VerfasserIn]
Solanki, Ani [VerfasserIn]
Shen, Jingjing [VerfasserIn]
Kahn, Aaron P. Esser [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

570
Biology

doi:

10.1101/2024.03.22.585780

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI043072216